6539.TWO DV Biomed Co. Ltd.
- Market cap
- TWD 847M
- P/E
- 11.1x
- P/B
- 1.60x
- ROE
- 1.5%
- Dividend yield
- 4.38%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 6539.TWO undervalued?
Graham number6539.TWO trades 11.1% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
DV Biomed Co. Ltd. fundamental analysis
No fundamental analysis for DV Biomed Co. Ltd. yet.
DV Biomed Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About DV Biomed Co. Ltd.
DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and China. The company provides health and slimming services; and distributes medical aesthetic fillers and aesthetic medical equipment. It also offers functional beverages and supplements, including beauty, slimming, supplements, and other products; skincare; and beauty products and services, as well as operates beauty therapy centers. The company was founded in 2011 and is based in Taipei…
Full company profileDV Biomed Co. Ltd. financial statements
DV Biomed Co. Ltd. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 1.93B | 1.81B | 1.83B | 1.87B | 619M | 574M | 794M |
| Gross Profit | 977M | 926M | 1.02B | 1.04B | 483M | 425M | 567M |
| Operating Income | 158M | 270M | 417M | 386M | 150M | 108M | 14.9M |
| EBITDA | - | - | - | 554M | 186M | 146M | 47.0M |
| Net Income | 166M | 301M | 305M | 281M | 163M | 89.1M | 7.74M |
| EPS | 2.69 | 14 | 12 | 12 | 6.69 | 11 | 0.32 |
| Balance Sheet | |||||||
| Total Assets | 1.98B | 1.83B | 1.86B | 828M | 595M | 777M | 677M |
| Total Liabilities | 761M | 624M | 684M | 191M | 119M | 243M | 170M |
| Shareholders' Equity | 1.03B | 1.20B | 1.18B | 637M | 476M | 534M | 507M |
| Cash & Short-term Investments | 595M | 534M | 558M | 391M | 226M | 214M | 114M |
| Cash Flow | |||||||
| Operating Cash Flow | 227M | 463M | 523M | 523M | 69.6M | 119M | 57.5M |
| Capital Expenditure | 155M | 93.9M | 69.3M | 122M | 2.52M | 6.21M | 40.4M |
| Free Cash Flow | 72.1M | 369M | 453M | 400M | 67.1M | 113M | 17.1M |
| Ratios | |||||||
| ROE | 16.2% | 25.0% | 25.8% | 44.2% | 34.2% | 16.7% | 1.5% |
| ROA | 8.4% | 16.5% | 16.3% | 34.0% | 27.4% | 11.5% | 1.1% |
| Net Profit Margin | 8.6% | 16.6% | 16.7% | 15.1% | 26.3% | 15.5% | 1.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
DV Biomed Co. Ltd. dividends
- Dividend yield
- 4.38%
- Forward dividend
- 1.60 TWD
- Payout ratio
- 480.1%
- Ex-dividend date
- Aug 27, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | TWD 37.1M | 1.53 | 480.1% |
| 2024 | TWD 80.4M | 9.77 | 90.3% |
| 2023 | TWD 299M | 12 | 183.5% |
| 2022 | TWD 307M | 13 | 109.0% |
| 2021 | TWD 326M | 13 | 107.0% |
| 2020 | TWD 98.0M | 4.70 | 32.5% |
| 2019 | TWD 122M | 1.98 | 73.7% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1180:1000 on Aug 28, 2025.
Who owns DV Biomed Co. Ltd.
Ownership data of DV Biomed Co. Ltd. is not available yet.
DV Biomed Co. Ltd. company profile
- Company name
- DV Biomed Co. Ltd.
- Ticker
- 6539.TWO
- Exchange
- Taiwan OTC Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Fiscal year end
- December
- Address
- No.1, Songzhi Rd, Taipei, Taiwan, 110411
- Phone
- 886 2 2791 1826
- Website
- dvbiomed.com
About DV Biomed Co. Ltd.
DV Biomed Co., Ltd. manufactures and sells medical-grade skin care products in Taiwan and China. The company provides health and slimming services; and distributes medical aesthetic fillers and aesthetic medical equipment. It also offers functional beverages and supplements, including beauty, slimming, supplements, and other products; skincare; and beauty products and services, as well as operates beauty therapy centers. The company was founded in 2011 and is based in Taipei, Taiwan.
DV Biomed Co. Ltd. management
4- Liqi ZhangPresident & Chairman
- Huang Qing JunChief Financial Officer
- Li Yi YunChief Operating Officer
- Mingfeng HeChief Accounting Officer